• Home
  • Events
  • Immuno-oncology in GU malignancies - the next evolution of treatment
Back to all events
28 Feb 2020
  • Victorian Comprehensive Cancer Centre

Immuno-oncology in GU malignancies - the next evolution of treatment

Associate Professor Niall Corcoran, VCCC Research & Education Lead for GU cancers, would like to invite you to register for a special VCCC symposium addressing the rapid development of immunotherapies in GU malignancies.

The symposium aims to raise awareness of the latest treatment advances in bladder, renal and prostate cancer, to share learnings from the management of these new drugs and to collectively discuss some of the unanswered immuno-oncology questions.

Plenary Presentation

black 2017 0Dr Peter Black

Senior Research Scientist, Vancouver Prostate Centre
Professor, Department of Urologic Sciences, University of British Columbia

Dr Black is a surgeon scientist with clinical sub-specialty interest in the treatment of urologic cancers, especially bladder and prostate cancer. Dr Black trained with one of the premier bladder cancer research groups in the world at M.D. Anderson Cancer Center in Houston, Texas, and has now established a research group at the Vancouver Prostate Centre.  

Some of his research interests include novel targeted therapies for bladder cancer. Dr Black is an active clinical trialist in this field and is study chair of the SWOG S1605 trial testing an immune checkpoint inhibitor in BCG-unresponsive high-risk non-muscle invasive bladder cancer. 

He has authored >240 peer-reviewed publications and his scientific work has been published in >350 abstracts at national and international meetings. He is a consultant/adviser to GenomeDx Biosciences, Janssen, Astellas, Amgen, Sitka, AbbVie, Bristol Myers Squibb, Bayer, Biosyent, Sanofi, Urogen, and Roche/Genentech.


Associate Professor Paul Neeson, Cancer Immunology Group Leader, Peter MacCallum Cancer Centre

Associate Professor Andrew Weickhardt, Senior Clinical Research Fellow, Olivia Newton-John Cancer Research Institute and Medical Oncologist, Austin Health

Associate Professor Renea Taylor, Senior Lecturer and Research Fellow, Department of Physiology and Biomedicine Discovery Institute, Monash University

Associate Professor Shahneen Sandhu, Consultant Medical Oncologist and Researcher, Peter MacCallum Cancer Centre

Associate Professor Shankar Siva, Radiation Oncologist and NHMRC Fellow, Peter MacCallum Cancer Centre

Dr Paul Anderson, Consultant Urologist, Royal Melbourne Hospital

Associate Professor Joseph Ischia, Urologist, Austin Health and University of Melbourne

Dr Shirley Wong, Consultant Medical Oncologist, Western Health

There will be an opportunity to share your thoughts during interactive case-based and panel discussions.

 Download the program


Friday 28 February 2020, 8.00am - 12.30pm
VCCC Building, Level 7 Lecture Theatre 


Registration is FREE, includes light refreshments

Please contact Lauren King, Program Manager, VCCC Research and Education Lead Program, if you have any questions.